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The PSD-95/SAPAP/Shank complex functions as the
major scaffold in orchestrating the formation and
plasticity of the post-synaptic densities (PSDs). We
previously demonstrated that the exquisitely specific
SAPAP/Shank interaction is critical for Shank synap-
tic targeting and Shank-mediated synaptogenesis.
Here, we show that the PSD-95/SAPAP interaction,
SAPAP synaptic targeting, and SAPAP-mediated
synaptogenesis require phosphorylation of the
N-terminal repeat sequences of SAPAPs. The atomic
structure of the PSD-95 guanylate kinase (GK) in
complex with a phosphor-SAPAP repeat peptide,
together with biochemical studies, reveals the mo-
lecular mechanism underlying the phosphorylation-
dependent PSD-95/SAPAP interaction, and it also
provides an explanation of a PSD-95 mutation found
in patients with intellectual disabilities. Guided by the
structural data, we developed potent non-phosphor-
ylated GK inhibitory peptides capable of blocking
the PSD-95/SAPAP interaction and interfering with
PSD-95/SAPAP-mediated synaptic maturation and
strength. These peptides are genetically encodableCell Repor
This is an open access article under the CC BY-Nfor investigating the functions of the PSD-95/SAPAP
interaction in vivo.INTRODUCTION
Dendritic spines are tiny membrane protrusions from dendritic
shafts, and they play critical roles in synaptic transmissions.
The post-synaptic density (PSD) at the distal tip of dendritic
spine heads refers to a densely packed multi-protein structure
orchestrating synaptic formation and function (Carlin et al.,
1980; Chen et al., 2008; Sheng and Kim, 2011). As central signal
transduction hubs at synapses, the PSDs are enriched with
neurotransmitter receptors, adhesion molecules, scaffold pro-
teins, signaling enzymes, and cytoskeletal components (Baye´s
and Grant, 2009; Dieterich and Kreutz, 2016; Kim and Sheng,
2004; Sheng and Hoogenraad, 2007). Scaffold proteins serve
as bridges linking the upstream glutamate receptors (i.e.,
NMDA-type glutamate receptors [NMDARs] and AMPA-type
glutamate receptors [AMPARs]) with the downstream signaling
complexes and cytoskeletons. Accordingly, spatial and tempo-
ral organization of scaffold protein-mediated protein complexes
at the core of the PSD is pivotal for synaptic signaling and
plasticity (Won et al., 2017; Zhu et al., 2016b). Mutations of
genes encoding the PSD scaffold proteins have been frequently
associated with various psychiatric disorders, including autismts 21, 3781–3793, December 26, 2017 ª 2017 The Author(s). 3781
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spectrum disorder (ASD), obsessive-compulsive disorder
(OCD), intellectual disability (ID), and schizophrenia (Balan
et al., 2013; Grant, 2012; Lelieveld et al., 2016; Pinto et al.,
2010; Ting et al., 2012; Volk et al., 2015).
The PSD-95 family of membrane-associated guanylate ki-
nases (MAGUKs), including PSD-95, PSD-93, SAP102, and
SAP97, are the most abundant scaffold proteins in the PSDs.
PSD-95 directly binds to SAPAP (also known as DLGAP or
GKAP), which in turn binds to the Shank family proteins, forming
the PSD-95/SAPAP/Shank core complex of PSD (Kim et al.,
1997; Naisbitt et al., 1999; Takeuchi et al., 1997). This core
complex is thought to be critical for synaptic development and
transmission. Many lines of evidence have indicated that PSD-
95 MAGUKs are essential for trafficking and anchoring of synap-
tic glutamate receptors (Chen et al., 2015; Elias and Nicoll, 2007;
Opazo et al., 2012). Loss of PSD-95 MAGUKs led to a reduction
in the number of synapses containing glutamate receptors and
defects in both AMPAR and NMDAR transmissions (Levy et al.,
2015). Likewise, removal of SAPAP or Shank also results in
the loss of AMPAR-containing synapses and weaker synaptic
transmissions (Hung et al., 2008; Shin et al., 2012).
Recent super-resolution imaging studies have revealed that
major synaptic scaffold proteins, such as PSD-95 and SAPAP,
form co-clustered nanodomains with glutamate receptors (e.g.,
AMPAR) in the PSDs (MacGillavry et al., 2013; Nair et al.,
2013). Alteration of the level of PSD-95 changes the number
and area of AMPAR nanodomains and synaptic transmissions
(MacGillavry and Hoogenraad, 2015; Nair et al., 2013).
Importantly, the subsynaptic co-clustering of PSD-95/AMPAR
alters in response to synaptic activities (Fukata et al., 2013;
MacGillavry and Hoogenraad, 2015; Zhu et al., 2016b), though
with poorly understood molecular mechanisms.
Given the fundamental roles that the PSD-95/SAPAP/Shank
core complex plays in orchestrating the assembly of the PSDs
as well as in regulating the dynamic changes of synaptic
morphology and plasticity, it is not surprising that mutations of
the genes encoding these proteins can cause severe psychiatric
disorders and neurodevelopmental diseases (Grant, 2012;
Marı´n, 2012). For example, DLG4 (encoding PSD-95) knockout
mice showed increased repetitive behaviors and abnormal so-
cial behaviors reminiscent of ASD and Williams’ syndrome
(Feyder et al., 2010). Human genetic studies also indicated that
DLG4 is a possible candidate gene for ID and schizophrenia
(Balan et al., 2013; Lelieveld et al., 2016; Rauch et al., 2012).
Mice with genetic deletion of Sapap3 or Sapap2 exhibited
increased anxiety-like and aggressive behaviors relevant to
OCD and ASD (Jiang-Xie et al., 2014; Welch et al., 2007).
Increasing evidence suggests that the Sapap family genes are
tightly associated with the neuropathology of ASD, OCD, and
Tourette’s syndrome in humans (Bienvenu et al., 2009; Crane
et al., 2011; Pinto et al., 2010; Stewart et al., 2013; Z€uchner
et al., 2009). Mutations of Shank-encoding genes are highly
penetrant in causing ASD (Pec¸a et al., 2011; Pinto et al., 2010;
Ting et al., 2012).
A better understanding of the molecular basis underlying the
PSD-95/SAPAP/Shank complex formation can provide valuable
insights into the physiological roles of the complex in synapse
formation and function as well as the mechanisms of brain disor-3782 Cell Reports 21, 3781–3793, December 26, 2017ders caused by alterations of these genes. Recent biochemical
and structural studies have demonstrated the exquisitely spe-
cific interaction between Shank and SAPAP (Zeng et al., 2016).
However, how the SAPAP/Shank complex is recruited to the
PSDs is still rudimentarily understood. SAPAP1 was shown to
bind guanylate kinase (GK) domains of PSD-95 and MAGI2,
and the interactions have been mapped to several 14-amino
acid repeats (referred to as GK-binding repeats [GBRs]) at the
N terminus of SAPAP1 (Hirao et al., 1998; Kim et al., 1997; Nais-
bitt et al., 1997). We and others have demonstrated that the GK
domain of MAGUKs functions as a phosphoprotein-binding
module (Johnston et al., 2012; Zhu et al., 2011, 2014). Moreover,
phosphor-SAPAP1 GBR peptides have been shown to bind
to PSD-95 SH3-GK (Zhu et al., 2011), suggesting that
the PSD-95/SAPAP interaction may be regulated by phos-
phorylation. However, the molecular mechanism governing
the phosphorylation-dependent PSD-95/SAPAP interaction
has not been elucidated.
In this work, we solved the crystal structure of PSD-95 GK in
complex with a synthetic phosphor-SAPAP1 GBR peptide (i.e.,
pSAPAP1-R2). The complex structure not only elucidates the
molecular basis underlying the specific and likely synaptic activ-
ity-regulated PSD-95/SAPAP interaction but also provides a
mechanistic explanation for the etiology of ID caused by a
mutation identified in PSD-95. We further demonstrated that
the phosphorylation-dependent PSD-95/SAPAP interaction is
crucial for SAPAP synaptic targeting and SAPAP-mediated syn-
aptogenesis. We successfully designed several non-phosphory-
lated GK inhibitory peptides, and we solved the structure of
PSD-95 SH3-GK in complex with one of the GK inhibitory pep-
tides. We went on to demonstrate that the most potent GK inhib-
itory peptide can effectively block the PSD-95/SAPAP interac-
tion and impair synaptogenesis when expressed in cultured
neurons.
RESULTS
Crystal Structure of PSD-95 GK in Complex with a
Phosphorylated SAPAP1 Peptide
Analysis of the GBR sequences in the SAPAP family of proteins
(SAPAP1–4) reveals a highly consensus motif of -R-x-x-S-Y-x-
x-A-, where ‘‘x’’ denotes any residue (Figure 1A). We previously
demonstrated that two phosphorylated SAPAP1 GBRs bind to
PSD-95 SH3-GK in a fluorescence polarization-based assay
(Zhu et al., 2011). Here we first confirmed the PSD-95 GK/
SAPAP interaction using purified recombinant PSD-95 GK and
two synthetic phosphor-SAPAP peptides (i.e., phosphor-SA-
PAP1-GBR2 [pSAPAP1-R2] and phosphor-SAPAP3-GBR1
[pSAPAP3-R1]). Isothermal titration calorimetry (ITC)-based
assays showed that PSD-95 GK binds to pSAPAP1-R2 and
pSAPAP3-R1 with Kd values of 0.08 and 0.07 mM, respectively
(Figure 1B). As expected, the unphosphorylated SAPAP pep-
tides (i.e., SAPAP1-R2 andSAPAP3-R1) displayed no detectable
binding to PSD-95 GK (Figure 1B). Given that the sequences of
GBR motifs in SAPAPs are extremely conserved, it is expected
that all of the phosphor-SAPAP-GBRs can bind to PSD-95 GK
with high affinity and dephosphorylation of Ser(0) in each GBR
would eliminate its binding to PSD-95.
Figure 1. Biochemical and Structural Char-
acterization of PSD-95/SAPAP Interaction
(A) Schematic diagram of the domain organiza-
tions of PSD-95 and SAPAP family proteins
(SAPAP1–4). The interaction between PSD-95 and
SAPAPs is indicated by a two-way arrow. The
amino acid sequence alignment of the GK-binding
repeat (GBR) of human SAPAPs is also shown.
In this alignment, the absolutely conserved and
conserved residues are color in red and green,
respectively. The consensus GK-binding motif -R-
x-x-S-Y-x-x-A- is shown beneath the alignment.
(B) ITC-based measurements of the binding
affinities between phosphor- and unphosphor-
SAPAP1-R2 or SAPAP3-R1 peptides and PSD-
95 GK.
(C) Ribbon diagram representation of the crystal
structure of PSD-95 GK in complex with the
phosphor-SAPAP1-GBR2 peptide (pSAPAP1-
R2). The phosphate group of pSAPAP1-R2 is
shown in the ball-and-stick model.
(D) Superposition of the structures of PSD-95 GK/
pSAPAP1-R2 (light blue, this study), SAP97 SH3-
GK/pLGN (purple; PDB: 3UAT), and PSD-95 GK/
pLgl2 (red; PDB: 3WP0).To better understand the molecular details of the PSD-95
GK/phosphor-SAPAP interaction, we solved the complex
structure of PSD-95 GK/pSAPAP1-R2 at 2.3-A˚ resolution
(Table S1). Each asymmetric unit contains two copies of the
complex with very similar conformation. In the complex,
PSD-95 GK adopts a typical GK domain architecture, and
the pSAPAP1-R2 peptide forms a short helix engaging the ca-
nonical phosphopeptide-binding pocket of PSD-95 GK (Zhu
et al., 2016b) (Figure 1C). Including this study, four crystal
structures of DLG GK/phosphopeptide complexes (i.e.,
SAP97 SH3-GK/pLGN [Zhu et al., 2011], PSD-95 GK/pLgl2
(two structures with distinct pLgl2 peptides) [Zhu et al.,
2014], and PSD-95/pSAPAP1-R2 in this study) have been
determined. Superposition of these structures reveals several
common features of the DLG GK/phosphopeptide interac-
tions (Figure 1D): each bound phosphopeptide contains a
short a helix in its N-terminal half; DLG GK recognizes diverse
phosphopeptides via similar binding sites formed by the GMP-
binding (GMP-BD) and the CORE/LID subdomains; peptide
binding does not induce large conformational changes to the
DLG GK domains.Cell ReportsThe PSD-95 GK/pSAPAP1-R2
Interface
The complex structure reveals that the
pSAPAP1-R2-binding site on GK con-
sists of two key elements: the phos-
phor-site and the hydrophobic site. The
phosphate group of the pSAPAP1-R2 is
coordinated by side chains of R568,
R571, and Y580 at the phosphor-site.
These polar interactions are further
strengthened by intramolecular interac-
tions between side chains of R568,E574, and Y609 of GK (Figure 2A). As expected, alterations of
the phosphor-site of GK (the R568, R571, Y580, and Y609A
quadruple mutant) totally disrupted the GK/pSAPAP1-R2 inter-
action (Figure 2C; Table S2). Substitution of pSer of pSAPAP1-
R2 and pSAPAP3-R1 with Ala abolished the GK/pSAPAP1-
R2 and GK/pSAPAP3-R1 interactions (Figure 2C). Surprisingly,
substitution of pSer of pSAPAP1-R2 and pSAPAP3-R1 with
Glu also disrupted the interactions (Figure 2C), suggesting that
the Ser-to-Glu substitution in SAPAP GBRs cannot be used as
a phosphor-mimetic mutation for investigating the PSD-95/SA-
PAP interaction. This is distinct from our previous finding that
the phosphor-mimetic mutant of LGN could still retain modest
binding to DLG GK (Zhu et al., 2011).
The hydrophobic site of GK is occupied by the short a helix
formed by pS(0) to T(+5) of pSAPAP1-R2 (Figures 2A and 2B).
The side chains of Y(+1) and A(+4) of pSAPAP1-R2 insert into
the hydrophobic pocket formed by Y580, Y604, and Y609 from
GK (Figure 2B). In addition to forming the hydrophobic interac-
tions with the hydrophobic site of GK, the side chain of Y(+1)
of pSAPAP1-R2 forms hydrogen bonds with the side chains of
E600 and T611 of GK. This is a unique feature of the GK/pSAPAP21, 3781–3793, December 26, 2017 3783
Figure 2. Detailed Interface of the PSD-95 GK/pSAPAP1-R2 Complex
(A) Stereo view of detailed interaction between PSD-95 GK and the pSAPAP1-R2 peptide. Dotted lines denote hydrogen bonds and salt bridge interactions.
(B) The combined ribbon and surface representation of the PSD-95 GK/pSAPAP1-R2 complex. The hydrophobic residues, positively charged residues, and
negatively charged residues of GK are color in yellow, blue, and red, respectively.
(C) Summary of ITC-based measurements of the binding affinities between the wild-type and mutants of PSD-95 GK and the pSAPAP1-R2 peptide.
(D) CoIP assay showing that both the S394, 500A (S2A) and S394, 500E (S2E) mutants of SAPAP3 significantly decreased their bindings to PSD-95.interaction compared to other GK/target interactions (Zhu et al.,
2011, 2014, 2016a). In line with the critical roles of Y(+1) and
A(+4) of pSAPAP1-R2 in the complex formation, substitutions
of either Y(+1) with Ala or A(+4) with Gln eliminated the GK/
pSAPAP1-R2 interaction (Figure 2C). Importantly, substitution
of either T611 or E600 from GK with Ala also significantly weak-
ened its binding to pSAPAP1-R2 (Figure 2C), supporting the
specific role of the hydrogen bonds between these two residues
and the hydroxyl group of Y(+1) observed in the complex struc-
ture (Figure 2A; also see Figure 6 discussing a PSD-95 mutation
found in ID patients).
Besides the residues involved in the twomajor interaction sites
discussed above, several polar interactions further contribute to
the specific GK/pSAPAP1-R2 interaction. For example, the side
chain of R(-3) of pSAPAP1-R2 forms charge-charge interactions
with the side chains of D545 and D629 of GK. The side chain of
R(-2) of pSAPAP1-R2 forms hydrogen bonds with the main
chains of R578 and D579 from GK. Fitting the structural
analysis, substitution of R(3) with Ala weakened the binding
of pSAPAP1-R2 to GK by 3.5-fold (Figure 2C).
We then tested the phosphorylation-dependent interaction
between the full-length PSD-95 and the full-length SAPAP ex-3784 Cell Reports 21, 3781–3793, December 26, 2017pressed in heterologous cells. We used the FLAG-tagged
wild-type (WT) SAPAP3 or its mutants for co-immunoprecipita-
tion (coIP) of GFP-tagged PSD-95. SAPAP3 contains two GBR
motifs (Figure 1A). We verified that the SAPAP3-R1 peptide
binds to PSD-95 GK also in a strict phosphorylation-dependent
manner. Substitution of pSer(0) with Ala or Glu also eliminated
the binding of pSAPAP3-R1 to PSD-95 (bottom four rows in
the right column of Figure 2C). As expected, SAPAP3 WT
showed a robust binding to PSD-95 in the coIP assay (Fig-
ure 2D). Both the phosphor-deficient mutant (S394, 500A,
referred to as S2A) and the phosphor-mimetic mutant (S394,
500E, referred to as S2E) of SAPAP3 showed significantly
weaker binding to PSD-95 (Figure 2D). Our data are consistent
with a report showing that both the phosphor-deficient mutant
(S54, 201A double mutant) and phosphor-mimetic mutant
(S54, 201D double mutant) of SAPAP1 displayed diminished
bindings to PSD-95 GK in yeast two-hybrid assays (Shin
et al., 2012). Taken together, we concluded that phosphoryla-
tion of GBR motifs in SAPAP is critical for the PSD-95/SAPAP
interaction and the S/E substitutions in the SAPAP GBRs cannot
be used to mimic phosphorylation-induced binding of SAPAP to
PSD-95.
Figure 3. Phosphorylation-Dependent PSD-
95/SAPAP Interaction Is Crucial for the Syn-
aptic Targeting of SAPAP
(A) Representative images of transfected hippo-
campal neurons at DIV17.
(B and C) Quantification of the imaging data
showing synaptic targeting of various SAPAP3
constructs. Synaptic enrichment ratio of SAPAP3
is defined as: [GFPspine/GFPshaft]/[mCherryspine/
mCherryshaft]. Twelve neurons (i.e., n = 12) from four
independent batches of cultures were imaged for
each group for quantifications. Error bar indicates ±
SEM. **p < 0.01; NS, not significant. One-way
ANOVA with Tukey’s multiple comparison test was
used for the plot in (B). (C) shows the cumulative
frequency plot of synaptic enrichment ratio of
various forms of SAPAP3.Phosphorylation-Dependent PSD-95/SAPAP Interaction
Is Critical for SAPAP Synaptic Targeting and Dendritic
Spine Development
Since PSD-95 and SAPAP colocalize with each other along den-
dritic spines in cultured hippocampal neurons (Kim et al., 1997;
Shin et al., 2012), we next investigated whether the phosphory-
lation-dependent PSD-95/SAPAP interaction is required for the
synaptic targeting of SAPAP. The GFP-tagged SAPAP3 WT
and its two PSD-95 binding-deficient mutants, S2A and S2E,
were individually co-transfected with mCherry in cultured hippo-
campal neurons at day in vitro 14 (DIV14). Neurons were fixed for
further imaging analysis at DIV17. As expected, the expressed
GFP-SAPAP3WT showed prominent spine localization, whereas
both the S2A and S2E mutants of SAPAP3 were less enriched in
spines and more diffused to dendritic shafts (Figure 3A). Quanti-
tative synaptic enrichment ratio data (normalized by mCherry in-
tensity) further confirmed that the synaptic targeting efficiency of
the SAPAP3 S2A mutant was significantly lower than SAPAP3
WT (Figures 3B and 3C; WT = 2.45 ± 0.15 and S2A = 1.88 ±
0.09; **p < 0.01, one-way ANOVA with Tukey’s multiple compar-
ison test). Notably, SAPAP3 S2E exhibited targeting deficiency
very similar to that of SAPAP3 S2A (Figures 3B and 3C; S2E =
1.89 ± 0.09). In line with this observation, in COS-7 cells, the
S2D mutant (S54, 201D double mutant) of SAPAP1 did not co-
cluster with PSD-95, whereas SAPAP1 WT and PSD-95 formed
perfect co-clustering (Kim et al., 1997; Romorini et al., 2004; Shin
et al., 2012). Collectively, these data indicate that the phosphor-
ylation-dependent interaction between PSD-95 and SAPAPs is
critical for synaptic targeting of SAPAPs.
Dendritic spines undergo dramatic morphological changes
during development. In mature neurons, the shapes of spines
dynamically change in response to diverse neuronal stimuli, anCell Reportactivity that is tightly associated with
various forms of synaptic plasticity. Given
that a set of key scaffold proteins (e.g.,
PSD-95, SAPAP, Shank, Homer, etc.)
plays essential roles in synaptic develop-
ment (Levy et al., 2015; Sala et al., 2001;
Zeng et al., 2016), we next evaluated the
role of the specific PSD-95/SAPAP inter-action in synaptogenesis. In this assay, we classified the spines
with a mushroom-like head as mature spines (featuring larger-
diameter spine heads), while others, including filopodia-like,
stubby, branchy, and thin mushroom, we classified as immature
spines. FLAG-tagged SAPAP3 constructs (WT, S2A, and S2E)
were transfected into cultured hippocampal neurons (DIV14),
and GFP was co-transfected with each SAPAP3 construct to
outline the morphology of dendritic spines and as the back-
ground transfection control (Figure 4A). Compared to the GFP
or SAPAP3 WT group, neurons overexpressing SAPAP S2A or
S2E showed more filopodia-like and less mushroom-like spines
at DIV17 (Figure 4A). Quantifications of the images revealed that
overexpression of either SAPAP3 S2A or SAPAP3 S2E led to
a significant reduction in the proportion of mature spines
compared to the control neurons (i.e., the GFP-alone group or
the SAPAP3 WT group) (Figure 4B; GFP = 0.33 ± 0.02, WT =
0.39 ± 0.03, S2A = 0.15 ± 0.02, and S2E = 0.18 ± 0.02;
***p < 0.001 and ****p < 0.0001, one-way ANOVA with Tukey’s
multiple comparison test). We also quantified the effect of
PSD-95/SAPAP3 interaction on spine morphology by measuring
the spine head width using ImageJ software (Zeng et al., 2016).
Neurons expressing SAPAP3 WT showed a mild but significant
increase of spine head width compared to the control neurons
expressing GFP only (Figures 4C and 4D). In contrast, neurons
expressing either SAPAP3 S2A or SAPAP3 S2E showed a prom-
inent reduction in spine head width, which is consistent with
above mature spine ratio analysis (Figures 4C and 4D; GFP =
0.52 ± 0.01 mm, WT = 0.59 ± 0.03 mm, S2A = 0.41 ± 0.01 mm,
and S2E = 0.35 ± 0.01 mm; *p < 0.05, **p < 0.01, ***p < 0.001,
and ****p < 0.0001, one-way ANOVA with Tukey’s multiple com-
parison test). The above data indicate that the phosphorylation-
dependent interaction between PSD-95 and SAPAP is crucial fors 21, 3781–3793, December 26, 2017 3785
Figure 4. Overexpression of SAPAP3 S2A/S2E Mutants Leads to Defects in Dendritic Spine Development
(A) Representative images of transfected hippocampal neurons at DIV17. Arrowheads indicate mature spines with a mushroom-like head, and arrows represent
immature spines including filopodia, branchy, stubby, and thin mushroom types of spines.
(B) Quantification of image data showing reduction of mature spines for the neurons expressed the SAPAP3 S2A and S2Emutants. Eight neurons (i.e., n = 8) from
three independent batches of cultures were imaged for each group for quantifications. Error bar indicates ± SEM. ***p < 0.001, ****p < 0.0001; NS, not significant.
One-way ANOVA with Tukey’s multiple comparison test.
(C) Quantification of imaging data showing reduction in spine head width for the S2A and S2E SAPAP3 mutants expressing neurons. *p < 0.05, **p < 0.01, and
****p < 0.0001, one-way ANOVA with Tukey’s multiple comparison test.
(D) Cumulative frequency plot of spine head width of neurons expressing various forms of SAPAP3.dendritic spine development. Expression of the SAPAP3 S2A or
SAPAP3 S2E mutants appears to have a dominant-negative
effect on dendritic spine development in cultured neurons.
Disruption of the PSD-95/SAPAP Interaction by a
Designed Non-phosphor Inhibitory Peptide
We next tried to evaluate the possible impact of disruption of
the PSD-95/SAPAP interaction on synaptogenesis. Although
the above-characterized phosphor-SAPAP peptides can be
used to effectively block the PSD-95/SAPAP complex formation
in vitro, they may not be effective tools for in vivo studies in neu-
rons due to their poor cell penetration (Dunican and Doherty,
2001; Ye et al., 2007) and susceptibility of the phosphate group
to removal by protein phosphatases in the cellular milieu.
Another limitation of these phosphopeptides is that they cannot
be genetically encoded for cellular or in vivo expressions.
Furthermore, the phosphor-mimetic mutations of the SAPAP
peptides are not effective in disrupting the PSD-95/SAPAP inter-
action either (Figure 2C). Therefore, we attempted to use the
structural knowledge of the DLG GK/phosphopeptide interac-
tions to design non-phosphopeptides that are capable of dis-
rupting the PSD-95/SAPAP interaction.
Based on the sequence analysis of the DLGGK-binding phos-
phopeptides and the four DLG GK/phosphopeptide complex3786 Cell Reports 21, 3781–3793, December 26, 2017structures, the peptide-binding interface on GK can be arbitrarily
separated into the following 7 sites (Xia et al., 2017; Zhu et al.,
2011, 2014, 2016b; this study) (Figure 5A): (1) pSer site, which
coordinates the phosphate group of phosphopeptides or the
side chain of pSer-mimicking Glu/Asp of non-phosphopeptides;
(2) the hydrophobic site formed by P564, Y580, Y604, and Y609
of GK, which accommodates Y(+1)/A(+4)pSAPAP1-R2, M(+1)/
L(+4)pLGN, and L(+1)/S(+4)pLgl2, respectively; (3) the hydrophobic
cradle formed by I593, A601, and L608 of GK, which coordinates
M(+7)pLGN or F(+9)pLgl2; (4) an Asp residue cluster (D545,
D549, and D629 of GK) coordinating with R(3)pSAPAP1-R2 or
K(+1)pLgl2; (5) the main chains of R578 and D579 of GK, which
form hydrogen bonds with R(2)pLGN or R(2)pSAPAP1-R2; (6) a
hydrophobic pocket formed by L552 and I627 of GK; and (7)
the positively charged R637 beneath the hydrophobic cradle of
GK. It is noted that the pLGN and pLgl2 peptides utilize interac-
tions between their C-terminal tails (i.e., residues beyond the +5
position) and site 3 of GK to enhance their bindings to GK (Zhu
et al., 2011, 2014), and such interactions do not exist in the
PSD-95/pSAPAP complex (Figures 2A and 2B). Thus, we
reasoned that a chimeric phosphomimicking peptide that fuses
the optimal SAPAP peptide with the C-terminal tails of the LGN
peptide or Lgl2 peptide would enhance the chimeric SAPAP
peptide’s binding to PSD-95 GK.
Figure 5. Designed Non-phosphopeptide Inhibitors of GK Effectively Block the PSD-95/SAPAP Interaction and Modulate Synaptogenesis
(A) Structure-based sequence alignment of known targets of DLG GKs. The phosphorylated Serines are color in red and positioned as ‘‘0’’ (top). The positively
charged and hydrophobic residues are color in blue and orange, respectively. The bottom panel showing the surface representation of the PSD-95 GK which
consists of seven binding sites for its target proteins.
(B) Summary of ITC-based measurements of the binding affinities between designed GKIs and PSD-95 GK.
(C) Ribbon diagram representation of the crystal structure of PSD-95 SH3-GK in complex with the GKI-QSF peptide. The side chain of E0 of the GKI-QSF peptide
is shown in the ball-and-stick model. The side chain of F(+10)QSF is also shown.
(D) Detailed interactions between PSD-95 GK and the QSF peptide. Dotted lines denote hydrogen bonds and salt bridge interactions.
(E) Superposition of structures of GK/pLGN (PDB: 3UAT), GK/pLgl2 (PDB: 3WP0), and GK/GKI-QSF (this study) showing that the side chain of F(+10) in the
designed QSF peptide occupies a very similar position on the Site-3 of GK as M(+7)pLGN and F(+9)pLgl2 do in their complex with DLG GK.
(F) Pull-down-based competition experiment showing that the DLS peptide can effectively disrupt the PSD-95 GK/SAPAP3 interaction, whereas the DLS E2A
mutant incapable of binding to PSD-95 GK cannot.
(G) Quantification of spine head width for neurons overexpressing designed GFP-fused peptides. Twelve neurons (i.e., n = 12) from four independent batches of
cultures were imaged for each group for quantifications. Error bar indicates ± SEM. ****p < 0.0001; NS, not significant, using one-way ANOVA with Tukey’s
multiple comparison test.
(legend continued on next page)
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Accordingly, the following three chimeric phosphomimicking
GK inhibitory peptides (referred to as GKIs) were designed:
QSF, RIRREEYRRANGQSF; MKL, RIRREEYRRANGQSMKL;
and DLS, RIRREEYRRANGQSFDLS (Figure 5B). The designing
strategy was as follows: a bulky hydrophobic Ile was used to
substitute A(4) of SAPAP-R2 for targeting site 6 of GK, and
an Arg was placed at the 5 position for possible favorable
interaction with the negatively charged residues in site 4 of GK
(Figure 5A); a more bulky Ile was used to substitute T(+5) of
SAPAP-R2 for better binding to the hydrophobic site (i.e.,
site 2) of GK; and the three different C-terminal tail sequences
were designed to target the hydrophobic cradle (i.e., site 3) of
GK that is not used by the pSAPAP-R2 peptide (Figure 2) but
is engaged by the pLGN or pLgl2 peptides (Figure 5E). A two-
residue linker (‘‘NG’’) was used to connect the C-terminal tail
with the optimal SAPAP-R2. Satisfyingly, ITC-based assays
revealed that these non-phosphorylated GKI peptides bound
to PSD-95 GK with Kd values ranging from 0.66 to 1.86 mM (Fig-
ure 5A). Notably, the DLS peptide bound to GK with a stronger
affinity than other GKIs did, whichwas probably due to additional
interaction between D(+11)DLS and R637 in site 7 of GK (Fig-
ure 5A). One would expect that the phosphorylated GKIs would
have even stronger binding to PSD-95 GK. Indeed, the phos-
phorylated DLS peptide (pDLS) bound to PSD-95 GK with
a super strong binding affinity (Kd 2 nM) (Figure 5B). Taken
together, the above biochemical data indicate that the strategy
we used to design specific GKIs works well.
To further rationalize the enhanced GK bindings of these GKIs,
we tried to crystallize various GKIs in complex with PSD-95 GK
or SH3-GK. We were able to obtain the high-diffraction-quality
crystals of the PSD-95 SH3-GK/QSF peptide complex, and we
solved the structure at 2.35-A˚ resolution (Table S1). In the com-
plex, the residues from E(0) to I(+5) of the QSF peptide formed
an expected a-helical structure binding to site 1 and site 2
on GK. The carboxyl group of E(0) interacted with R568, R571,
and Y609 in a way similar to that of pSer (Figures 5C and 5E).
In agreement with our design strategy, I(4)QSF interacted with
hydrophobic residues in site 6 of GK (Figure 5D; Figure S1A).
Somewhat surprisingly, the side chain of R(+2)QSF occupied
the same position as the side chain of R(3)pSAPAP1-R2 did by
forming salt bridges with the side chains of D545 and D549
(site 4) of GK (Figures 5A and 5D; Figure S1A). Most notably,
the side chain of F(+10)QSF coupled with the hydrophobic cradle
(site 3) of GK in a manner similar to that of M(+7)pLGN or F(+9)pLgl2
in their respective complex with GK (Figures 5A, 5D, and 5E; Fig-
ure S1A). We believe that F(+10) plays a critical role in enhancing
the binding of the QSF peptide to PSD-95 GK. In line with these
structural analyses, substitution of E(0)QSF with Ala dramatically
weakened its binding to PSD-95 GK; substitution of A601 in the
shallow hydrophobic cradle of GK accommodating F(+10)QSF
with Asp also decreased PSD-95 GK’s binding to the QSF pep-
tide by 4-fold (Figures S1B–S1D).(H) Representative recordings of the miniature EPSCs (mEPSCs) and miniatu
expressing GFP, GFP-DLS-E2A, or GFP-DLS.
(I) The mean amplitudes (left) and the frequencies (right) of mEPSCs and mIPSCs
t test. (n = 9 recordings/4 mice/group; ***p < 0.001 and ****p < 0.0001).
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SAPAP interaction in vitro. Since the DLS peptide binds to
PSD-95 GK with the strongest binding affinity, we thus chose
the DLS peptide for further study. As expected, glutathione
S-transferase (GST)-tagged PSD-95 GK could robustly pull
down FLAG-tagged SAPAP3 expressed in heterologous cells
(Figure 5F, lane 3). Addition of the DLS peptide in the reaction
mixture significantly reduced the interaction between PSD-95
GK and SAPAP3 (Figure 5F, lane 4), whereas the DLS E2A
mutant peptide (i.e., substituting E(0) with Ala; also see Fig-
ure S1D) had no impact on the binding (Figure 5F, lane 5), further
confirming the specificity of the DLS peptide in blocking the
PSD-95/SAPAP interaction.
Given that the DLS peptide can effectively block the PSD-95/
SAPAP interaction in vitro, we next investigated whether this
peptide can effectively modulate the synaptogenesis when ex-
pressed in neurons. In this assay, GFP-DLS, GFP-DLS E2A,
and GFP-R1R2 (SAPAP3 fragment containing two GBR motifs)
were individually co-transfected with mCherry into cultured
hippocampal neurons (DIV14). mCherry alone was also trans-
fected as a control. At DIV17, all groups of neurons were fixed
and analyzed for dendritic spine morphology. Neurons express-
ing the DLS peptide showed a significant decrease of spine head
width compared with those expressing mCherry alone, the DLS
E2A peptide, or the R1R2 peptide (Figure 5G; Figure S2;
mCherry = 0.48 ± 0.01 mm, DLS = 0.39 ± 0.01 mm, E2A =
0.45 ± 0.01 mm, and R1R2 = 0.45 ± 0.01 mm; ****p < 0.0001,
one-way ANOVA with Tukey’s multiple comparison test; R1R2
peptide: a SAPAP3 fragment containing two GBR motifs in
tandem), indicating that blocking the synaptic PSD-95/SAPAP
interaction can interfere with dendritic spine development in
cultured neurons.
We further investigated whether the DLS peptide can effec-
tively modulate synaptic activity. EGFP-fused DLS peptide,
the GFP-fused control peptide DLS-E2A, and GFP alone were
expressed in the CA1 region of the dorsal hippocampus of adult
mice using Lenti-DLS-GFP, Lenti-DLS-E2A-GFP, and Lenti-
GFP virus vectors, respectively (Figure S3). The miniature excit-
atory postsynaptic currents (mEPSCs) and miniature inhibitory
postsynaptic currents (mIPSCs) from CA1 pyramidal neurons
in the hippocampal slices expressing GFP, GFP-DLS-E2A, or
GFP-DLS were recorded using whole-cell patch-clamp tech-
niques (Figures 5H and 5I). Both the amplitudes and fre-
quencies of mEPSCs in neurons expressing DLS were signifi-
cantly reduced compared with those expressing either GFP
or the GFP-DLS-E2A control (Figure 5I). In contrast, the
mIPSCs in neurons expressing DLS-GFP did not differ from
those expressing either GFP or GFP-DSL-E2A (Figure 5I).
These data indicate that the delivery of the DLS peptide into
neurons specifically weakens the excitatory synaptic strength
and acts most likely through disrupting the synaptic PSD-95/
SAPAP interaction.re IPSCs (mIPSCs) from CA1 pyramidal neurons in the hippocampal slices
are shown in bar graphs. Data are presented as mean ± SEM using Student’s
Figure 6. The Effect of ID-Associated PSD-
95 T611I Mutation on the Formation of the
PSD-95/SAPAP Complex
(A) The structure-based sequence alignment
showing that T611 is totally conserved among
all members of the DLG family MAGUKs.
In this alignment, the absolutely conserved and
conserved residues are color in red and green,
respectively. The conserved T611 residues are
highlighted with a yellow box.
(B) The combined ribbon and ball-and-stick repre-
sentations showing that the side chain of ID-asso-
ciated PSD-95 T611 residue, together with the side
chain of PSD-95 E600, forms hydrogen bond
network with the absolutely conserved Tyr at the +1
position of the pSAPAP1-R2 peptide.
(C) The ITC-based measurement of the binding
affinity of the PSD-95 GK-T611I/pSAPAP1-R2
interaction.
(D) CoIP assay showing that T611I mutant of PSD-
95 weakens the PSD-95/SAPAP binding.Mechanistic Insights into an ID-Associated Mutation in
PSD-95 GK
PSD-95 has been associated with a variety of brain disorders,
including ID, schizophrenia, and ASD (Balan et al., 2013; Feyder
et al., 2010; Lelieveld et al., 2016; Nithianantharajah et al., 2013).
We noted with interest that a missense mutation of PSD-95
(T611I) was identified by a large-scale exome sequencing of pa-
tients with ID (Rauch et al., 2012). Sequence alignment analysis
showed that T611 was absolutely conserved among the DLG
family of MAGUKs (Figure 6A). On the basis of the PSD-95
GK/pSAPAP1-R2 complex structure solved in this study,
T611PSD-95 locates in the binding interface between GK and
pSAPAP, and the side chain of T611 forms a hydrogen bond
with Y(+1) of pSAPAP1-R2 (Figure 6B). Therefore, substitution
of T611 with Ile was expected to affect the PSD-95/pSAPAP
interaction. Indeed, the T611I mutant of PSD-95 GK showed
an12-fold decrease of binding to pSAPAP1-R2 (Figure 6C; Fig-
ure 2C). CoIP assay also demonstrated that T611I mutation
significantly decreased the interaction between the full-length
PSD-95 and the full-length SAPAP3 (Figure 6D). Given that the
tight and specific interaction between PSD-95 and SAPAPs is
important for synapse development and maturation, our struc-
tural and biochemical data provide a mechanistic explanation
of why the T6611I mutation of PSD-95 found in patients may
interfere with synapse development and cause ID.
DISCUSSION
The PSD-95/SAPAP/Shank complex plays vital roles in synaptic
development and activities by interfacing the glutamate recep-Cell Reportors on the synaptic plasma membranes
and actin cytoskeleton at the deeper layer
of PSD. Recently, we discovered an exqui-
sitely strong bindingmode between Shank
and SAPAP that determines the highly
specific Shank/SAPAP complex formation
as well as targeting of Shank to synapses(Zeng et al., 2016). In the present study, we provide biochemical
and structural evidence showing that the interaction between
PSD-95 and SAPAP is also very strong and specific (Kd in the
range of a few dozens of nanomolar). Most importantly, we
demonstrate that the specific interaction between PSD-95 and
SAPAPs is phosphorylation dependent. Phosphorylation of a
highly conserved Ser residue in each GBR motif of SAPAPs
switches on the interaction between PSD-95 and SAPAPs.
Removal of the phosphate group from the Ser in GBR eliminates
the binding of SAPAPs to PSD-95 (Figure 1). We also provide ev-
idence to show that the phosphorylation-dependent PSD-95/
SAPAP interaction is required for SAPAP’s synaptic targeting
and dendritic spine development (Figures 3 and 4). These find-
ings indicate that the formation of the PSD-95/SAPAP complex
in PSD is regulated by synaptic activities, providing an avenue
for dynamic regulation of PSD assemblies. It is envisioned that
changes of synaptic activity and ensuing alterations of pro-
tein kinase/phosphatase activity can modulate phosphorylation
status of the GBR motifs in SAPAPs and, thus, regulate the
formation of the PSD-95/SAPAP complex.
Our above finding immediately raises a number of questions:
(1) Are SAPAPs phosphorylated in vivo and to what extent are
SAPAPs phosphorylated? (2) Which kinase(s) phosphorylates
SAPAPs? (3) Which phosphatase(s) acts to remove the phos-
phorylation? (4) How are the activities of the kinase(s) and phos-
phatase(s) coordinated with synaptic signals? Proteomic studies
have indicated that SAPAPs are indeed phosphorylated in vivo
(Collins et al., 2005; Trinidad et al., 2005, 2008). Moreover, the
GBR motifs of SAPAPs have been shown to be phosphorylated
by CaMKII directly in vitro and in cultured neurons (Collins et al.,ts 21, 3781–3793, December 26, 2017 3789
2005; Shin et al., 2012; Trinidad et al., 2005), thus linking the key
synaptic activity regulatory kinase with the PSD-95/SAPAP com-
plex formation. It is noted that the consensus sequence (-R-x-x-
S-Y-x-x-A-) from the GBR motifs of SAPAPs fits well with the
substrate recognition sequences of other kinases, including pro-
tein kinase A (PKA), protein kinase C (PKC), and protein kinase D
(PKD) (Ubersax and Ferrell, 2007; Wang et al., 2012); it is
tempting to speculate that SAPAPs might also be phosphory-
lated by these kinases in synapses. CaMKII, PKA, and PKC are
all known to be tightly associated with synaptic development
and plasticity via phosphorylating a wide spectrum of synaptic
proteins (Boehm et al., 2006; Okamoto et al., 2009; Zhong
et al., 2009). Therefore, the phosphorylation-dependent PSD-
95/SAPAP interaction can, in principle, provide a regulated
switch of assembly/disassembly of PSD components, which is
likely coupled to synaptic activity changes. Future work is
required to validate whether the direct coupling between regu-
lated PSD-95/SAPAP-mediated PSD assembly and dynamic
changes in synaptic activity is indeed present in neurons
and, if the answer is yes, how such coupling is modulated via
synaptic activity-dependent modulations of specific kinases
and phosphatases.
Mammals contain four paralogs of DLGs and four SAPAPs.
The existence of multiple highly homologous paralogs of these
two major PSD scaffold proteins have posed major challenges
in investigating their roles in synaptic development and func-
tions, in large part due to compensatory effects among themem-
bers. It is desirable to develop tools that can specifically modu-
late the interactions between the DLG family and the SAPAP
family proteins for studying their functional roles in synapses un-
der both physiological and pathological conditions. Based on the
structures of DLG GK/target complexes elucidated in this work
and our earlier studies, we successfully designed a non-phos-
phopeptide that can specifically inhibit the formation of the
PSD-95/SAPAP complex (Figure 5A). Given that the GK domains
of DLGs share essentially the same phosphopeptide-binding
property (Zhu et al., 2011, 2014) and the SAPAPs contain highly
conserved GBR motifs, our developed GKI is expected to be
able to block the complex formation between all paralogs of
the DLG family and the SAPAP family proteins. Our developed
GKI does not require Ser(0) in GBR motifs to be phosphorylated,
and thus it should be more stable when delivered to living neu-
rons. Perhaps most importantly, such non-phosphopeptide
can be genetically encoded and paired with any tagging se-
quences, such as fluorescence proteins or specific cellular tar-
geting motifs, for various cell biology studies of the functions
of the DLG/SAPAP interactions. We have provided a proof-of-
concept use of such inhibitory peptide by studying their impact
on the synaptic targeting of SAPAPs and synaptogenesis and
synaptic activity using neuronal culture as well as brain slice cul-
ture as the models (Figure 5). We note that the binding affinity of
the best GKI (the DLS peptide; Figure 5), although with aKd value
at a sub-micromolar range, is still about 10-fold lower than the
naturally occurring phosphor-GBR motif peptides (Figures 5B
and 2C). Further work is required to develop GKIs with even
higher binding affinities to the DLG GK domains.
Finally, the structure of the PSD-95 GK/pSAPAP1-R2 complex
determined in this study, together with our systematic biochem-3790 Cell Reports 21, 3781–3793, December 26, 2017ical investigations, not only elucidates the mechanistic basis
governing the phosphorylation-dependent PSD-95/SAPAP
complex formation but also provides a foundation for under-
standing why certain mutations of the genes encoding the
two major scaffold proteins may cause neuronal diseases in
humans.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Preparations of the rat PSD-95 GK domain (amino acid residues 531–713;
NCBI sequence: NP_062567) and various mutants followed the previously
described methods (Zhu et al., 2011, 2014). All the phosphor- or non-phos-
phor-SAPAP peptides and the GKIs were commercially synthesized (China
Peptides).
ITC Assay
ITC measurements were performed on a MicroCal iTC200 system (Malvern) in
a buffer containing 50 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, and 1 mM
DTT at 25C. The concentrations of proteins loaded into the syringe and the
cell were 0.5 and 0.05mM, respectively. The titration data were analyzed using
Origin7.0 from MicalCal and fitted by a one-site binding model. The error on
each Kd value represents the SE for the fit of the curve from each titration
experiment. The summary of parameters of ITC assays in this study are listed
in Table S2.
Protein Crystallization and Structure Determination
Crystals of the PSD-95 GK/pSAPAP1-R2 complex and the PSD-95 SH3-GK/
GKI-QSF complex were obtained by the hanging drop vapor diffusion method
at 16C. The PSD-95 GK/pSAPAP1-R2 complex crystals were grown in 0.1 M
ammonium acetate, 0.1 M Bis-Tris (pH 5.5), and 17% w/v polyethylene glycol
10,000. The PSD-95 SH3-GK/GKI-QSF complex crystals were grown in 0.1 M
Tris (pH 8.0) and 35% tert-butanol; 25% glycerol was added as the cryo-pro-
tectant before diffraction data collection. The structures were both solved by
the molecular replacement method using PSD-95 SH3-GK structure (PDB:
1KJW) as the search model with Phaser (McCoy et al., 2007) in CCP4 (Murshu-
dov et al., 2011). Refinements were carried out using phenix.refinement
(Adams et al., 2010). The pSAPAP-R2 peptides and the GKI-QSF peptide
were manually built. Further model buildings and adjustment were completed
using Coot (Emsley et al., 2010). The structural diagrams were prepared by the
program PyMOL (www.pymol.org).
CoIP Assay and GST Pull-Down Assay
For coIP assays, FLAG-tagged SAPAP3 and GFP-tagged PSD-95 and their
various mutants were co-expressed in HEK293T cells. After 24 hr of transfec-
tion, cells were lysed in the ice-cold cell lysis buffer containing 50 mM HEPES
(pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EGTA, 1% Triton, and protease
inhibitor cocktail for 1 hr at 4C, followed by centrifugation at 12,000 rpm for
10 min at 4C. In each reaction, the supernatant was incubated with 20 mL
anti-FLAG M2 magnetic beads (Sigma-Aldrich) for 1 hr at 4C. After extensive
washing, the captured proteins were separated by SDS-PAGE and detected
by western blot using specific antibodies.
For the GST pull-down assay, HEK293T cells expressing the FLAG-tagged
SAPAP3 were lysed in the ice-cold cell lysis buffer, followed by centrifugation
at 12,000 rpm for 10 min at 4C. The supernatant was incubated with 20 mL
glutathione Sepharose beads loaded with GST-GK with or without GKIs for
2 hr at 4C. After extensive washing, the captured proteins were separated
by SDS-PAGE and detected by western blot using anti-FLAG antibody
(Sigma).
Primary Hippocampal Neuron Culture
Hippocampal neuron cultures were prepared as previously described (Zeng
et al., 2016). At DIV14, neurons were transfected with 2 mg plasmids per well
(12-well plate) using Lipofectamine 2000 reagent (Invitrogen). Neurons were
fixed at DIV17 with 4% paraformaldehyde (PFA) together with 4% sucrose in
13PBS buffer and mounted on slides for imaging.
Image Acquisition and Quantification
Confocal images were obtained using a Leica SP8 confocal microscope with
a 403 oil-immersion lens. Transfected neurons were chosen randomly for
quantification from at least three independent batches of cultures. For detailed
spine visualization, an additional 53 zoom factor was applied. Normally,
four randomly selected dendrites (60 mm in length each) were imaged and
analyzed from an individual neuron. Each image was collected as a z series
maxim projection with 0.35-mmdepth intervals. Intensity and spine head width
were measured with ImageJ.
Stereotaxic Injection
Mice (C57BL/6, 4–5 weeks old, male) were anesthetized with isoflurane
(2%–5%) and then placed in a stereotaxic device where the head was fixed
and the skull was exposed. Burr holes were made, and a microsyringe (World
Precision Instruments) was slowly lowered into the dorsal CA1 at 2.06 mm
anteroposterior, 1.38 mm mediolateral, and 1.60 mm dorsoventral relative to
bregma. For the electrophysiological experiments, 200 nL virus was pres-
sure-injected into each hemisphere. The syringe remained in place for 5 min
and was then slowly retracted out. The mice were placed on a heating pad
during the surgery. After virus injection, the scalp was sutured and saline
was administered subcutaneously. The mice were placed on the heating
pad during recovery from anesthesia. The electrophysiological experiments
were conducted 2 weeks after the virus injection. Mice were bred and reared
under the conditions in accordance with institutional guidelines and the Animal
Care and Use Committee of the animal core facility at Huazhong University of
Science and Technology, Wuhan, China.
Electrophysiology
Hippocampal slices (300 mm) were prepared as described previously (Tu et al.,
2010). The slices were transferred to a holding chamber that contains artificial
cerebrospinal fluid (in mM: 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 1.2
MgCl2, 10 C6H12O6, and 2 CaCl2 [pH 7.4], 305mOsm). The slices were allowed
to recover at 31.5C for 30 min and then at room temperature for 1 hr. Acute
slices were transferred to a recording chamber continuously, which was
perfused with oxygenated artificial cerebrospinal fluid (2 mL/min) and main-
tained at room temperature. For whole-cell patch-clamp recordings from
the CA1 pyramidal cells, hippocampal slices were visualized via IR-DIC by
using an Axioskop 2FS equipped with Hamamatsu C2400-07E optics (Hama-
matsu City, Japan). Basic electrophysiological properties were recorded when
stable recordings were achieved with good access resistance (20 MU). The
mEPSCs were recorded using an internal solution containing (in mM) 140
potassium gluconate, 10 HEPES, 0.2 EGTA, 2 MgATP, 2 NaCl, and 0.3 NaGTP
and an external solution containing 10 mM bicuculline and 1 mM tetrodotoxin
(TTX). The mIPSCs were recorded with an internal solution containing (in
mM) 153.3 CsCl,1 MgCl2, 5 EGTA, 10 HEPES, 4 MgATP and an external
solution containing 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX),
50 mM APV, and 1 mM TTX. The data were collected at 10 kHz and filtered
with a low-pass filter at 2 kHz. Miniature events were analyzed in Clampfit
10.2 software (Molecular Devices, Sunnyvale, CA, USA) using templatematch-
ing and a threshold of 5 pA.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the atomic coordinates of the PSD-95 GK/
pSAPAP1-R2 complex and of the PSD-95 SH3-GK/QSF complex reported
in this paper are PDB: 5YPO and 5YPR, respectively.
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